SkylineDx Publishes Trial Results on Predictive Power of Melanoma Test in JAMA Surgery
By Karen Roman Oncology-focused biotech company SkylineDx said results from its MERLIN_001 trial, the largest evaluation of a genomic test in cutaneous melanoma, were published...
